Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Three-dimensional chromatin landscapes in MLLr AML [RNA-Seq]
GEO Series GSE244470. Homo sapiens. 4 samples. Type: Expression profiling by high throughput sequencing.
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
ClinicalTrials.gov study NCT03926624. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Perpetrator Drug Interactions of Enasidenib in AML Patients
ClinicalTrials.gov study NCT03720366. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML)
ClinicalTrials.gov study NCT02140606. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PF-05212384 (PKI-587) for t-AML/MDS or de Novo Relapsed or Refractory Acute Myeloid Leukemia (AML) (LAM-PIK)
ClinicalTrials.gov study NCT02438761. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML
ClinicalTrials.gov study NCT03690154. IPD Sharing: NO. Countries: 2. Publications: 0.
Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML
ClinicalTrials.gov study NCT02427919. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessing Refractoriness and Infectious Survival Events in AML
ClinicalTrials.gov study NCT06709235. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of a Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML)
ClinicalTrials.gov study NCT00764231. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT
ClinicalTrials.gov study NCT06447090. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Off-the-shelf CD123 CAR-NK for R/R AML
ClinicalTrials.gov study NCT06201247. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Avelumab With Decitabine as First Line for AML Treatment of Patients With AML, Who Are Unfit for Intensive Chemotherapy
ClinicalTrials.gov study NCT03395873. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML
ClinicalTrials.gov study NCT06420063. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML or HR-MDS
ClinicalTrials.gov study NCT07347418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
ClinicalTrials.gov study NCT05580861. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Universal CAR-γδT Cell Injection in the AML Patients
ClinicalTrials.gov study NCT05388305. IPD Sharing: NO. Countries: 1. Publications: 0.
Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60
ClinicalTrials.gov study NCT02234037. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
ClinicalTrials.gov study NCT06316960. IPD Sharing: NO. Countries: 1. Publications: 0.
Venetoclax in Combination With Azacitidine (VEN/AZA) Followed by Donor Lymphocyte Infusion (DLI) for Patients With Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell
ClinicalTrials.gov study NCT06158100. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
ClinicalTrials.gov study NCT05834244. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.